BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14987836)

  • 1. Inclusion complexes of 2-chloroethylnitrososulfamides (CENS) with beta-cyclodextrin.
    Kadri M; Dhaoui N; Abdaoui M; Winum JY; Montero JL
    Eur J Med Chem; 2004 Jan; 39(1):79-84. PubMed ID: 14987836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the composition and stability constant of inclusion complexes of beta-cyclodextrin with fluorouracil and ftorafur by NMR].
    Wen JQ; Cui W
    Yao Xue Xue Bao; 1990; 25(5):345-8. PubMed ID: 2284953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complex of fenbufen with beta-cyclodextrin.
    Bratu I; Gavira-Vallejo JM; Hernanz A; Bogdan M; Bora G
    Biopolymers; 2004 Mar; 73(4):451-6. PubMed ID: 14991662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.
    Béni S; Szakács Z; Csernák O; Barcza L; Noszál B
    Eur J Pharm Sci; 2007 Feb; 30(2):167-74. PubMed ID: 17145172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of N-sulfamoyloxazolidinones with beta-cyclodextrin.
    Kadri M; Djemil R; Abdaoui M; Winum JY; Coutrot F; Montero JL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):889-94. PubMed ID: 15686881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between beta-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state.
    Liu Y; Chen GS; Zhang HY; Song HB; Ding F
    Carbohydr Res; 2004 Jun; 339(9):1649-54. PubMed ID: 15183740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
    Liu Y; Chen GS; Chen Y; Lin J
    Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.
    Jullian C; Morales-Montecinos J; Zapata-Torres G; Aguilera B; Rodriguez J; Arán V; Olea-Azar C
    Bioorg Med Chem; 2008 May; 16(9):5078-84. PubMed ID: 18375132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
    Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
    Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
    Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
    J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
    Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
    Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
    Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F
    J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
    Yang ZX; Chen Y; Liu Y
    Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
    Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
    J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activity of water-soluble inclusion complexes of 1'-acetoxychavicol acetate with cyclodextrins.
    Azuma H; Aizawa Y; Higashitani N; Tsumori T; Kojima-Yuasa A; Matsui-Yuasa I; Nagasaki T
    Bioorg Med Chem; 2011 Jun; 19(12):3855-63. PubMed ID: 21596572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the inclusion compound of rutin with beta-cyclodextrin].
    Shao W; Wang D; Mi G; Wang C
    Zhong Yao Cai; 1998 Jan; 21(1):31-3. PubMed ID: 12567968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
    Sun DZ; Li L; Qiu XM; Liu F; Yin BL
    Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
    Yuexian F; Junfen L; Chuan D
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.